Epigenetic changes promoting cancer metastasis identified

December 21, 2016

Latest University of Otago research is shedding new light on why and how cancer cells spread from primary tumours to other parts of the body. This phenomenon – known as metastasis – causes about 90 per cent of all cancer deaths.

The Otago findings, published in the leading international journal Oncotarget, may pave the way for new therapies that prevent melanoma and other cancers from their deadly seeding of .

Department of Pathology researchers Dr Aniruddha Chatterjee and Professor Mike Eccles are lead authors of the study, which investigated in melanoma cells.

Epigenetics involves changes to the way genes behave – such as their being switched on or off through the addition of methyl groups to a gene's DNA segments.

After comparing primary and metastatic melanoma cells from the same patients, Dr Chatterjee says the research team identified thousands of epigenetic changes – and, crucially, several that were common to all the .

"We believe that these may be the key drivers that allow melanoma to metastasise," he says.

Additionally, the team identified a new function in melanoma of a gene called Early B Cell Factor 3 (EBF3).

"We found this gene gains more DNA methylation when primary melanoma progresses to its metastatic version, and that the gene expresses itself highly in the latter."

When the researchers used molecular techniques that decreased EBF3 expression, both primary and metastatic grew less aggressively and behaved less invasively.

Dr Chatterjee says earlier searches for genetic – rather than epigenetic – drivers of had not been very fruitful.

"Over the years, very few genetic mutations have been identified as drivers of metastasis. Instead, our approach looked at the changes in the way genes in are expressed, rather than changes to the genetic code itself," he says.

Dr Chatterjee says unlike genetic changes, epigenetic changes are reversible.

"So if we understand the key changes that underpin metastasis, then not only are we potentially able to monitor for their presence, but also to design new therapies to target and correct them to prevent metastasis of tumours."

Explore further: New research opens the 'black box' of malignant melanoma

More information: Chatterjee, A., Stockwell, P., Ahn, A., Rodger, E., Leichter, A., & Eccles, M. (2016). Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis. Oncotarget, 5. Retrieved from www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=14042&path%5B%5D=44772

Related Stories

New research opens the 'black box' of malignant melanoma

July 25, 2016

When malignant melanoma metastasizes to the brain, it is a death sentence for most patients. Metastatic melanoma is the deadliest of the skin cancers and the mechanisms that govern early metastatic growth and interactions ...

Fighting melanoma's attraction to the brain

September 19, 2012

(Medical Xpress)—The process of metastasis, by which cancer cells travel from a tumor site and proliferate at other sites in the body, is a serious threat to cancer patients. According to the National Cancer Institute, ...

Discovery may lead to targeted melanoma therapies

June 17, 2015

Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a study led by researchers at Icahn School of Medicine at Mount Sinai and published ...

Recommended for you

Scientists discover gene that blocks spread of colon cancer

April 21, 2017

Researchers from RCSI (Royal College of Surgeons in Ireland) and the University of Nice, France, have discovered the function of a gene called KCNQ1 that is directly related to the survival of colon cancer patients. The ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.